Medical and Wellness Tourism in Azerbaijan: A 2026 Overview
explainer · 9 min read
Azerbaijan's official statistics do include a small 'treatment purpose' arrivals figure, about 20,100 people in 2025, but nothing that breaks out Naftalan or any single sanatorium, so this guide works from what the State Statistics Committee actually tracks: total foreign arrivals, that treatment-purpose category, source-country mix, and government policy signals like the 2024 Naftalan decree. It maps every specialty cluster, Naftalan, Duzdag, Qalaalti, Chenot Gabala, and the Absheron sanatoriums, to what each one actually addresses, and benchmarks Azerbaijan against Turkey's much larger medical-tourism industry.
Azerbaijan's medical and wellness tourism runs on balneology, not surgery: Naftalan crude-oil baths, Duzdag salt-cave speleotherapy, mineral-water drinking cures, and physician-supervised longevity programs. The State Statistics Committee tracks total foreign arrivals, 2,626,700 in 2024, a record year, then 2,570,212 in 2025, a decline of about 2.15%, and its latest tourism yearbook adds a "treatment purpose" arrival line: about 20,100 people in 2025, down from 23,200 in 2024. That figure covers medical, dental, sanatorium, and spa travel together with no per-venue split, so any more specific "medical tourist" figure you read elsewhere, including on some travel-industry sites, is a third-party estimate rather than government data.
Birtour is a Baku-based DMC. We book stays across this cluster, Naftalan, Chenot Palace Gabala, Duzdag, and the wider sanatorium network, but we are not a medical provider and we do not operate any of the properties named on this page. Nothing here is medical advice. Suitability, contraindications, and treatment outcomes are set by each venue's own clinical team, not by us; the individual guides linked below carry the specific safety information for each modality.
Last reviewed: July 2026.
What is medical tourism in Azerbaijan?
Medical tourism in Azerbaijan means traveling for balneology, crude-oil immersion, salt-cave air, mineral-water drinking cures, and structured wellness programs, rather than for surgery, dentistry, or fertility treatment, the categories that dominate medical tourism in most other countries. The government has backed this positioning directly: a presidential decree signed 28 September 2024, titled "On Additional Measures Related to Increasing the Role of Naftalan Oil in the Development of Medical Tourism," names Naftalan oil as the flagship of the country's medical-tourism strategy.
That decree is a dated, concrete policy signal, and it now sits alongside one relevant official figure. Azerbaijan's State Statistics Committee tracks foreign visitors by purpose in broad buckets, tourism, business, transit, and so on, and within the tourism bucket its 2026 tourism yearbook lists a "treatment purpose" (müalicə məqsədilə) line: about 20,100 arrivals in 2025, down from 23,200 in 2024. That is a visa-declaration figure covering every kind of treatment-motivated travel together; it does not separate Naftalan guests from Duzdag guests, or from anyone else, so no sanatorium-specific count exists. A national health-tourism strategy is reportedly in development, benchmarked against Turkey, Malaysia, Czechia, and Thailand, but as of July 2026 no final targets or budget have been published, per caliber.az.
The asset base behind this push is large: roughly 930 mineral springs (120 of them surveyed in the liberated Karabakh and East Zangazur territories), an estimated 300 to 400 active mud volcanoes, and a naphthenic crude oil that only two places on earth use therapeutically: Naftalan itself and Ivanić-Grad, Croatia, where a refined derivative of the same oil is used instead of the raw crude. Tourism-board figures cited by caliber.az put roughly half of Azerbaijan's national health and wellness facilities in Naftalan alone. None of that scale, though, is reflected in a venue-level headcount; the treatment-purpose figure above is a national total, not a per-asset breakdown. Treat Azerbaijan's medical-tourism story as a set of confirmed assets, one confirmed policy decision, and one broad national arrivals figure, not yet a venue-level measured industry.
What treatments draw people to Azerbaijan?
Five distinct clusters draw medical and wellness travelers to Azerbaijan, each addressing a different condition set and resting on a different evidence base. None of them is a documented cure for anything on this list; the table states what each is used for and what the supporting evidence actually looks like.
| Modality | Location | What it addresses | Evidence status | Read more |
|---|---|---|---|---|
| Naftalan crude-oil balneotherapy | Naftalan town, about 330 km west of Baku | Psoriasis and other dermatoses during remission; inflammatory musculoskeletal and rheumatic pain | Observational clinical experience and small case series, no randomized trial for these indications | Naftalan oil therapy guide |
| Duzdag salt-cave speleotherapy | Duzdag, Nakhchivan (an Azerbaijani exclave) | Bronchial asthma, chronic bronchitis, allergic rhinitis | Venue-reported improvement rates; published reviews of speleotherapy describe the evidence as weak and inconsistent | Duzdag speleotherapy guide |
| Qalaalti mineral-water drinking cure | Shabran, about 120 km north of Baku | Urolithiasis and cholelithiasis (kidney and gallstones), taken as an on-site drinking cure | Traditional balneological use; the water's volatile organics mean it cannot be bottled or exported, and controlled evidence for stone clearance is limited | Wellness cluster overview |
| Chenot Palace Gabala | Gabala foothills, about 220 km from Baku | Physician-supervised detox, recovery, and prevention programs, structured around diet and physiotherapy rather than a named disease | A supervised wellness program; "biological-age" and "detox" language is marketing, not a documented trial outcome | Chenot Palace Gabala price guide |
| Absheron sanatorium cluster (Garangush, Gunashli, Bilgah Cardiological, Shikh, and others) | Mardakan, Bilgah, and Bibi-Heybat, all within about 40 km of Baku | Urological, neurological, gastrointestinal, and cardiovascular conditions, plus hydrogen-sulfide thermal baths for musculoskeletal disease, split by individual sanatorium | State tourism board-operated; per-venue clinical evidence has not been independently reviewed for this guide | Wellness cluster overview |
Naftalan carries the clearest government backing and the most third-party coverage. Qalaalti and the Absheron sanatoriums serve a mostly Russian-speaking and domestic patient base but publish less in English, so we route readers there to the wellness cluster overview rather than to a dedicated page until we can verify current per-venue pricing and booking terms directly.
Azerbaijan vs. Turkey for medical tourism
Turkey and Azerbaijan are not close competitors by scale. Turkey reported about 1.5 million international health visitors and roughly $3 billion in revenue in 2024, with a stated government target of $20 billion by 2028, built on surgical procedures, dentistry, hair transplants, and IVF. Azerbaijan's closest official figure, the treatment-purpose arrivals category, put about 20,100 people in that bucket in 2025, two orders of magnitude smaller than Turkey's count and not tracked as a dedicated medical-tourism industry at all.
| Turkey | Azerbaijan | |
|---|---|---|
| Reported medical/treatment-purpose arrivals | ~1.5 million (2024) | ~20,100 (2025), down from ~23,200 (2024); a broad treatment-purpose visa-declaration category, not sanatorium-specific |
| Reported medical-tourism revenue (2024) | ~$3 billion | Not published |
| Stated growth target | $20 billion by 2028 | No published target as of July 2026 |
| Core offer | Surgical, dental, and hair-transplant volume at competitive prices | Balneology and speleotherapy: Naftalan crude oil, Duzdag salt caves, mineral-water cures, physician-supervised wellness programs |
The honest comparison is not "which country treats more patients." It is that Azerbaijan is a small, emerging player positioned around a category Turkey barely competes in, crude-oil and mineral-water balneotherapy, rather than trying to out-price Turkish surgical and dental clinics. Georgia and Iran sit closer to Azerbaijan on scale, though we did not find clean current arrival counts for either during this research pass, so we are not publishing a three-way comparison table until those figures are confirmed.
How big is Azerbaijan's health tourism?
Azerbaijan's health tourism sector has no published size of its own at the venue level, though one relevant category does exist at the national level. Total foreign-visitor data: 2,626,700 arrivals in 2024, up 25.9% year on year and a record high, from 196 countries, per the State Statistics Committee. That growth did not carry into 2025: the committee's own 2026 tourism yearbook puts full-year 2025 arrivals at 2,570,212, a decline of about 2.15% year on year. The same yearbook splits those 2025 arrivals by purpose: 1,804,800 fall under "tourism purpose," and within that bucket sits a "treatment purpose" line of about 20,100 arrivals, down from 23,200 in 2024. That is the closest thing to an official medical-tourism headcount Azerbaijan publishes, and it is a broad one: medical, dental, sanatorium, and spa arrivals all sit inside the same figure, with no split by treatment type or by venue. That missing venue-level breakdown, not a missing statistic altogether, is the largest data limitation for anyone writing about this sector.
We are not going to fill the venue-level gap with a guess. Some travel-press pieces cite a figure of "15,000 Naftalan visitors a year," repeated often enough across outlets that it deserves a mention, but it comes from travel journalism, not from stat.gov.az. That estimate would sit inside the government's 20,100 treatment-purpose figure, not alongside it, and we still treat the Naftalan-specific number as order-of-magnitude only. If a page tells you exactly how many people visited Naftalan, or any single sanatorium, for treatment last year, ask where that number comes from, because the government publishes the category total, not a venue-by-venue breakdown.
What we can say with more confidence: the policy commitment exists on paper (the September 2024 Naftalan decree), the asset base is large (roughly 930 mineral springs, an estimated 300 to 400 mud volcanoes, and Naftalan's naphthenic crude oil), and the total inbound-tourism base this sector draws from grew sharply in 2024 before easing back in 2025, a dip the treatment-purpose figure mirrored too, down from 23,200 to 20,100. Whether that translates into a large or a small segment at any single venue, Naftalan versus Duzdag versus the Absheron sanatoriums, is not something the public data answers yet.
Who visits Azerbaijan for treatment?
No official source-market breakdown exists for medical or wellness visitors as a distinct group. What is published is the overall 2024 foreign-arrivals mix: Russia led at 27.8% of arrivals, followed by Türkiye at 16.2%, India at 9.3%, Iran at 8.0%, and Gulf countries combined at roughly 425,000 arrivals (about 16% of the total, up 21.4% year on year), all per the State Statistics Committee.
That overall mix is the closest proxy available, and it lines up with what industry sources say about the sanatorium sector specifically. Caliber.az describes Naftalan and the wider balneology network's visitor base as overwhelmingly Russian and CIS, with growing Gulf, Iranian, and Central Asian interest, and Azerbaijan's tourism board has run active Gulf-facing wellness marketing through partners like Wego, promoting Naftalan oil baths and the Lankaran and Masalli thermal springs to MENA travelers. None of that is a hard percentage split for medical visitors alone; it is a qualitative read from the same government arrivals data plus industry commentary, and we present it as exactly that.
What we don't claim
- We don't turn the government's treatment-purpose figure into a sanatorium headcount. Azerbaijan publishes about 20,100 treatment-purpose arrivals for 2025, down from 23,200 in 2024, a category that covers all treatment-motivated travel; every other figure on this page is either that data, clearly labeled, or a named third-party estimate flagged as unverified.
- We don't call any Azerbaijani sanatorium internationally accredited. Naftalan oil has not received full international medical certification as of mid-2026; Azerbaijani officials have described certification as underway, not complete.
- We don't quote a single cluster-wide price. Naftalan, Chenot Gabala, Duzdag, and Qalaalti price differently and change rates by season; each linked guide carries its own dated, sourced figures.
- We don't screen or diagnose. Whether a specific treatment suits a specific patient is the venue's clinical team's decision, made during intake, not ours.
For travelers or operators ready to book a specific stay, start with the modality that matches the condition: our Naftalan oil therapy guide, Chenot Palace Gabala price guide, and Duzdag speleotherapy guide each cover their own evidence, safety, and pricing in detail. For general trip logistics, our DMC quote request guide has the template that gets a fast, accurate answer.
- What is medical tourism in Azerbaijan?
- Azerbaijan's medical tourism centers on balneology: Naftalan crude-oil baths, Duzdag salt-cave speleotherapy, Qalaalti mineral-water cures, and the Absheron sanatorium cluster, plus physician-supervised longevity programs at Chenot Palace Gabala. It is not a surgical or dental hub. The State Statistics Committee does track a 'treatment purpose' arrival category, about 20,100 people in 2025, but it lumps medical, dental, sanatorium, and spa visits into one line, with no breakdown by venue.
- What treatments draw people to Azerbaijan?
- Naftalan oil baths for psoriasis (remission stage) and inflammatory joint pain, Duzdag salt-cave sessions for asthma and chronic bronchitis, Qalaalti drinking cures for kidney and gallstones, Absheron sanatoriums for urological, neurological, and cardiovascular conditions, and Chenot Gabala's supervised detox and prevention programs. Each rests on a different evidence base; none is a documented cure.
- How does Azerbaijan compare to Turkey for medical tourism?
- Turkey drew about 1.5 million international health visitors and roughly $3 billion in revenue in 2024, built on surgical, dental, and hair-transplant volume. Azerbaijan's closest official figure is its 'treatment purpose' arrival category, about 20,100 people in 2025, a fraction of Turkey's scale and not broken out by specialty. It is a small, emerging player differentiated by balneology and speleotherapy, not by procedure count or price competition with Turkish clinics.
- How big is Azerbaijan's health tourism industry?
- Azerbaijan's State Statistics Committee recorded 2,626,700 foreign arrivals in 2024, a record year, up 25.9%, then 2,570,212 in 2025, a decline of about 2.15%. Within that 2025 total, its tourism yearbook lists about 20,100 arrivals for treatment purpose, down from 23,200 in 2024, a broad visa-declaration category that groups all treatment-motivated travel together. It is not a sanatorium- or Naftalan-specific count, so any more granular medical-tourist figure you see elsewhere is a third-party estimate, not a government one.
- Who visits Azerbaijan for medical treatment?
- No official source-market breakdown exists for medical visitors specifically. Azerbaijan's overall 2024 arrivals skewed toward Russia (27.8%), Türkiye (16.2%), India (9.3%), and Iran (8.0%), with Gulf arrivals at about 425,000; industry commentary describes Naftalan and Duzdag's own visitor base as overwhelmingly Russian- and CIS-speaking, with growing Gulf and Iranian interest.
guide
Naftalan Oil Therapy in Azerbaijan: What It Treats, the Evidence, and Who Should Avoid It (2026)
guide
Chenot Palace Gabala: 2026 Prices, What's Included, and Is It Worth It?
guide
Duzdag Salt Cave, Nakhchivan: Speleotherapy for Asthma and Allergies (2026)
guide
Best Naftalan Sanatoriums Compared: Chinar, Garabag, Gashalti and the Rest (2026)
guide
Qalaalti Mineral Water and Kidney Stones: What the Shabran Spa Actually Offers (2026)